Sanofi Uroxatral Claim Construction Gets Judge's Nod
A federal judge has handed down a claim construction order for one of the patents in Sanofi-Aventis' multidistrict litigation alleging Mylan Pharmaceuticals Inc. and other generic-drug manufacturers have infringed its technology...To view the full article, register now.
Already a subscriber? Click here to view full article